Journal of psychoactive drugs
March 19, 2026
Pedro J Teixeira, Jorge Encantado, Helena D Amaro et al.
Portuguese adults who participate in ayahuasca ceremonies report good or very good health, with lower rates of chronic disease and obesity compared to the general population. They also report greater physical activity, lower alcohol consumption, and enhanced psychological well-being. Many attribute positive lifestyle changes, reduced substance use, and less reliance on prescription medication to their ayahuasca experiences. These findings align with prior research linking ayahuasca use to health and well-being, though causal pathways remain unclear.
Journal of psychoactive drugs
March 13, 2026
Matthew X Lowe, Quinn A Darby, Sasha Kalcheff-Korn et al.
Sexual and gender minority individuals face high rates of depression, anxiety, trauma, and discrimination but have been underrepresented in psychedelic research. A naturalistic study of a seven-day ayahuasca retreat for SGM participants found significant reductions in depression and anxiety scores and increases in spiritual well-being and quality of life, especially in the first month after the retreat. Participants described the experience as highly meaningful, with many ranking it among the most meaningful events of their lives. Positive behavioral changes included improved relationships and reduced substance use. Adverse effects were minimal and transient. The findings highlight the need for inclusive psychedelic spaces that support healing and identity affirmation for queer communities, reclaiming psychedelics from past misuse in conversion therapy.
Annali di Igiene Medicina Preventiva e di Comunità
March 10, 2026
Simone Esposito, Francesco Coletta, Francesca Schettino et al.
No Summary
Journal of Psychedelic Studies
March 9, 2026
Lajos Horváth
This paper extends Sartre's concept of enchanted consciousness by integrating insights from psychedelic research. It first examines contradictions in Sartre's mescaline experiment and limits of his phenomenological analysis of hallucination. Then it argues that Benny Shanon's typology of ayahuasca hallucinations, grounded in phenomenological cognitive psychology, reveals aspects of enchanted consciousness Sartre missed. The phenomenon of double bookkeeping from phenomenological psychiatry illustrates delusional world characteristics. Comparing pathological double bookkeeping with psychedelic bookkeeping expands the idea of enchanted consciousness. Finally, Sartre's views on hallucination are updated, defining captivated consciousness through psychedelic double bookkeeping.
Journal of psychopharmacology (Oxford, England)
March 9, 2026
Caio César De Paula, Anna Beatriz Vicentini, Lorena Terene Lopes Guerra et al.
A systematic review of 16 studies found that ayahuasca has distinct short- and long-term cognitive effects. In the short term, improvements in working memory and cognitive flexibility were observed, linked to neurochemical modulation of cortical networks. Observational studies reported increased empathy and emotion recognition, while experimental studies only found reduced reaction times in social cognition tasks. Long-term studies generally found no neuropsychological deficits, with some reporting improved memory and executive function. The review notes methodological limitations including small sample sizes, varied protocols, and potential learning effects, calling for more controlled, randomized studies.
Psychedelic medicine (New Rochelle, N.Y.)
March 1, 2026
Jonah Griffin-Stolbach, Hanna Molla, Donald Hedeker et al.
Questionnaires designed for high-dose psychedelic experiences fail to capture the subtle subjective effects of very low doses of LSD. Using data from 199 healthy volunteers given 6.5, 13, and 26 µg doses, a new 31-item questionnaire—the micro-dimensional Altered States of Consciousness (m-DASC)—was developed. It identifies four components: Transcendent Experience, Auditory Somatic Disturbance, Animated Intoxication, and Synesthesia, accounting for 44% of the variance. The m-DASC detected significant effects at 13 and 26 µg and correlated highly with longer questionnaires, offering a more sensitive tool for future low-dose psychedelic research.